- Home
- BSX vs BMY Comparison
BSX vs BMY Comparison
Compare BSX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- BMY
- Stock Information
- Founded
- BSX 1979
- BMY 1887
- Country
- BSX United States
- BMY United States
- Employees
- BSX N/A
- BMY N/A
- Industry
- BSX Medical/Dental Instruments
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- BSX Health Care
- BMY Health Care
- Exchange
- BSX Nasdaq
- BMY Nasdaq
- Market Cap
- BSX 157.6B
- BMY 94.0B
- IPO Year
- BSX 1992
- BMY N/A
- Fundamental
- Price
- BSX $99.87
- BMY $46.37
- Analyst Decision
- BSX Strong Buy
- BMY Hold
- Analyst Count
- BSX 22
- BMY 15
- Target Price
- BSX $118.91
- BMY $57.64
- AVG Volume (30 Days)
- BSX 6.7M
- BMY 9.6M
- Earning Date
- BSX 10-22-2025
- BMY 10-30-2025
- Dividend Yield
- BSX N/A
- BMY 5.35%
- EPS Growth
- BSX 36.90
- BMY N/A
- EPS
- BSX 1.68
- BMY 2.49
- Revenue
- BSX $18,494,000,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- BSX $19.75
- BMY N/A
- Revenue Next Year
- BSX $10.98
- BMY N/A
- P/E Ratio
- BSX $59.54
- BMY $18.65
- Revenue Growth
- BSX 21.44
- BMY 2.57
- 52 Week Low
- BSX $80.64
- BMY $42.96
- 52 Week High
- BSX $109.50
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- BSX 31.39
- BMY 44.49
- Support Level
- BSX $104.24
- BMY $45.85
- Resistance Level
- BSX $109.50
- BMY $48.19
- Average True Range (ATR)
- BSX 2.07
- BMY 0.89
- MACD
- BSX -0.66
- BMY -0.11
- Stochastic Oscillator
- BSX 1.88
- BMY 19.36
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.